Your browser doesn't support javascript.
loading
Response to anti-SARS-CoV-2 mRNA vaccines in multiple myeloma and chronic lymphocytic leukemia patients.
Zaleska, Joanna; Kwasnik, Paulina; Paziewska, Magdalena; Purkot, Joanna; Szabelak, Aleksandra; Jurek, Mateusz; Masny, Natalia; Dziatkiewicz, Izabela; Pronobis-Szczylik, Bartosz; Piebiak, Agnieszka; Szymczyk, Agnieszka; Jarosz-Chudzik, Katarzyna; Bolkun, Lukasz; Kozlowska, Katarzyna; Piszcz, Jaroslaw; Subocz, Edyta; Halka, Janusz; Bator, Michal; Kalicinska, Elzbieta; Wrobel, Tomasz; Usnarska-Zubkiewicz, Lidia; Rybka, Justyna; Deren-Wagemann, Izabela; Szyca-Smieszniak, Marta; Dybko, Jaroslaw; Hus, Iwona; Pula, Bartosz; Cichocka, Edyta; Rymko, Marcin; Zdunczyk, Dorota; Ziarkiewicz, Mateusz; Basak, Grzegorz Wladyslaw; Bullinger, Lars; Giannopoulos, Krzysztof.
Afiliación
  • Zaleska J; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Kwasnik P; Department of Hematology, St John's Cancer Centre, Lublin, Poland.
  • Paziewska M; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Purkot J; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Szabelak A; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Jurek M; Department of Hematology, St John's Cancer Centre, Lublin, Poland.
  • Masny N; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Dziatkiewicz I; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Pronobis-Szczylik B; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Piebiak A; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Szymczyk A; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Jarosz-Chudzik K; Department of Hematology, St John's Cancer Centre, Lublin, Poland.
  • Bolkun L; Department of Hematology, St John's Cancer Centre, Lublin, Poland.
  • Kozlowska K; Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland.
  • Piszcz J; Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
  • Subocz E; Department of Hematology, St John's Cancer Centre, Lublin, Poland.
  • Halka J; Department of Hematology, Medical University of Bialystok, Bialystok, Poland.
  • Bator M; Department of Hematology, Medical University of Bialystok, Bialystok, Poland.
  • Kalicinska E; Department of Hematology, Medical University of Bialystok, Bialystok, Poland.
  • Wrobel T; Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Olsztyn, Poland.
  • Usnarska-Zubkiewicz L; Department of Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Olsztyn, Poland.
  • Rybka J; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Deren-Wagemann I; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Szyca-Smieszniak M; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Dybko J; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Hus I; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Pula B; Department of Hematology and Transplantation, Lower Silesian Center of Oncology, Wroclaw, Poland.
  • Cichocka E; Department of Hematology and Transplantation, Lower Silesian Center of Oncology, Wroclaw, Poland.
  • Rymko M; Department of Hematology and Transplantation, Lower Silesian Center of Oncology, Wroclaw, Poland.
  • Zdunczyk D; Department of Clinical Transplantology, Medical University of Lublin, Lublin, Poland.
  • Ziarkiewicz M; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Basak GW; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Bullinger L; Department of Hematology and Bone Marrow Transplantation, Nicolaus Copernicus Hospital, Torun, Poland.
  • Giannopoulos K; Department of Hematology and Bone Marrow Transplantation, Nicolaus Copernicus Hospital, Torun, Poland.
Int J Cancer ; 152(4): 705-712, 2023 02 15.
Article en En | MEDLINE | ID: mdl-35830214
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Huésped Inmunocomprometido / COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Huésped Inmunocomprometido / COVID-19 / Vacuna BNT162 / Vacuna nCoV-2019 mRNA-1273 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Polonia